Credit Suisse’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $62.9M | Sell |
|
|||||
|
2023
Q4 | $82.4M | Sell |
|
|||||
|
2023
Q3 | $89.6M | Sell |
|
|||||
|
2023
Q2 | $100M | Buy |
|
|||||
|
2023
Q1 | $97.1M | Sell |
|
|||||
|
2022
Q4 | $99.8M | Buy |
|
|||||
|
2022
Q3 | $79.8M | Sell |
|
|||||
|
2022
Q2 | $67.7M | Sell |
|
|||||
|
2022
Q1 | $72.7M | Buy |
|
|||||
|
2021
Q4 | $71.6M | Buy |
|
|||||
|
2021
Q3 | $82.6M | Buy |
|
|||||
|
2021
Q2 | $93.9M | Sell |
|
|||||
|
2021
Q1 | $78.2M | Sell |
|
|||||
|
2020
Q4 | $93.1M | Sell |
|
|||||
|
2020
Q3 | $112M | Sell |
|
|||||
|
2020
Q2 | $128M | Buy |
|
|||||
|
2020
Q1 | $147M | Sell |
|
|||||
|
2019
Q4 | $143M | Sell |
|
|||||
|
2019
Q3 | $118M | Sell |
|
|||||
|
2019
Q2 | $126M | Buy |
|
|||||
|
2019
Q1 | $125M | Buy |
|
|||||
|
2018
Q4 | $132M | Buy |
|
|||||
|
2018
Q3 | $148M | Sell |
|
|||||
|
2018
Q2 | $123M | Sell |
|
|||||
|
2018
Q1 | $130M | Buy |
|
|||||
|
2017
Q4 | $144M | Sell |
|
|||||
|
2017
Q3 | $151M | Sell |
|
|||||
|
2017
Q2 | $135M | Sell |
|
|||||
|
2017
Q1 | $163M | Buy |
|
|||||
|
2016
Q4 | $150M | Sell |
|
|||||
|
2016
Q3 | $232M | Buy |
|
|||||
|
2016
Q2 | $163M | Buy |
|
|||||
|
2016
Q1 | $169M | Buy |
|
|||||
|
2015
Q4 | $195M | Sell |
|
|||||
|
2015
Q3 | $186M | Sell |
|
|||||
|
2015
Q2 | $283M | Buy |
|
|||||
|
2015
Q1 | $277M | Sell |
|
|||||
|
2014
Q4 | $242M | Buy |
|
|||||
|
2014
Q3 | $215M | Buy |
|
|||||
|
2014
Q2 | $175M | Buy |
|
|||||
|
2014
Q1 | $166M | Sell |
|
|||||
|
2013
Q4 | $180M | Buy |
|
|||||
|
2013
Q3 | $128M | Sell |
|
|||||
|
2013
Q2 | $142M | Buy |
|